HEIndividual fellowship2023–2025

GRAIN · Gene Regulatory Network Architecture in Neuronal Development

Horizon Europe — Marie Skłodowska-Curie Actions

Duration
2023-09-01 → 2025-08-31
EU contribution
€214,934
Participants
1
Scheme
HORIZON-TMA-MSCA-PF-EF

Lines connect the coordinator with its partners.

Results in brief

Gene Regulatory Network Architecture in Neuronal Development

In the original GRAIN project, we set out to define the gene regulatory network (GRN), i.e. the downstream set of genes that interact with one another to control a process, activated in the development of mesencephalic dopaminergic neurons, the cell type affected in Parkinson’s disease. Such network is driven by HES1, a downstream effector of Notch receptors, which mediates cell-cell contact dependent signalling and is crucial for fine tuning the balance between the maintenance of an adequate progenitor pool and the initiation of differentiation in many tissues. Due to unforeseen circumstances, six months within the start of the fellowship the project was subjected to a forced refocusing. Together with the new supervisor, we devised a project that addressed similar overarching questions and aims, in the context of a different signalling pathway (FGF/Erk signalling instead of Notch) and at a different developmental stage: the transition from naïve stem cells to primitive endoderm. During development, a single cell gives eventually rise to an embryo and its extraembryonic, supportive tissues. This process is highly inefficient, as only 30-40% of conceptions will lead to live births. Recent studies have highlighted an association between correct specification of primitive endoderm (PrE), a tissue that will become the yolk sac, and successful embryo implantation. On a molecular level, it’s been shown that these cells are, to some extent, plastic: they maintain the potential to regenerate themselves and other cell types. How is this possible? Recent research from the Brickman group has revealed that some pluripotency factors, such as Sox2, presumably more active in stem cells and gradually repressed in more differentiated tissues, like PrE, remain bound to their target genes even after the differentiation into PrE has begun. We hypothesize this could be a mechanism to allow for the memory of a previous plastic state. While the project tackles a fundamental question in biology, its results will help discover biomarkers or druggable targets that will become candidates for future translational research in the context of in vitro fertilization, to maximise successful embryo implantation.

Data: CORDIS, © European Union

Project objective

Stem cell-based therapy is an attractive way to treat a panel of as-yet incurable diseases, amongst which is Parkinson’s Disease, caused by the progressive degeneration of mesencephalic dopaminergic (mesDA) neurons. To make this a reality, efficient and precise differentiation protocols of human embryonic stem cells (hESCs) need to be developed. While a protocol for differentiation of mesDA neurons exists, little is known about the resulting progenitors’ homogeneity and the mechanisms that control their maintenance, expansion and differentiation. MesDA neurons arise from ventral midbrain progenitors, whose differentiation requires the transcription factor Neurogenin 2 (NGN2). NGN2 acts as a “master regulator” by binding to, and stimulating transcription of, a panel of poorly defined target genes, while itself negatively regulated by HES1, one of the main effectors of Notch signalling. Yet, the involvement of Notch signalling in mesDA differentiation and the composition of the HES1/NGN2 gene regulatory network (GRN), i.e. the group of genes under their transcriptional control, in this context remains largely unknown.The aim of this action is to determine the mechanisms by which HES1, NGN2 and their GRN control mesDA differentiation. Building upon and expanding existing tools and knowledge in the host lab, I will use a multidisciplinary approach combining genome editing and hESC biology to derive mesDA progenitors from a panel of wildtype and HES1/NGN2 KO hESCs cell lines, with a multiomics approach to define the members of the HES1/NGN2 GRN and unravel its mechanism of action. The synergy between the expertise of the host lab in developmental and stem cell biology, and my extensive knowledge of bioinformatics and experience in the generation of multiomics datasets, will allow to both improve the efficacy and quality of the current mesDA differentiation protocols, as well as expand fundamental knowledge about the architecture of GRNs regulated by Notch signalling.

Original text from CORDIS.

Participants

  • KOBENHAVNS UNIVERSITET · KOBENHAVNCoordinatorDenmark

Links

Data: CORDIS, © European Union